Gastroschisis
ORPHA:2368Morphological anomalyNot applicableAntenatal
Фенотипы (HPO)13
Очень частый (80–99%)1
HP:0001543Gastroschisis
Частый (30–79%)4
HP:0001511Intrauterine growth retardation
HP:0010881Abnormality of the umbilical cord
HP:0011432Elevated maternal circulating alpha-fetoprotein concentration
HP:0034207Abnormal fetal gastrointestinal system morphology
Периодический (5–29%)8
HP:0001561Polyhydramnios
HP:0001562Oligohydramnios
HP:0001622Premature birth
HP:0002566Intestinal malrotation
HP:0002580Volvulus
HP:0011100Intestinal atresia
HP:0031368Intestinal perforation
HP:0100016Abnormality of mesentery morphology
Эпидемиология20
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Prevalence at birth | 1-5 / 10 000 | 16.9 | Europe | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 29.4 | Austria | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 14.6 | Belgium | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 22.7 | Croatia | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 21.3 | Denmark | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 17.7 | France | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 41.6 | Germany | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 6.2 | Hungary | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 18.1 | Ireland | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 9.9 | Italy | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 25.8 | Malta | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 17.5 | Netherlands | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 36 | Norway | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 11.6 | Poland | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 11 | Portugal | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 5.6 | Spain | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 12.3 | Switzerland | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 36.3 | United Kingdom | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 9.5 | Ukraine | Value and class |
| Point prevalence | 1-5 / 10 000 | — | Europe | Class only |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)